![Emergent Biosolutions Inc](/common/images/company/L_0IGA.png)
Emergent Biosolutions Inc (0IGA)
LSE
The current 0IGA market cap is 2.68B. The company's latest EPS is USD -14.6577 and P/E is -0.64.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.11B | 1.56B | 1.79B | 1.12B | 1.05B |
Operating Income | 114.1M | 433.8M | 352.6M | -172.7M | -726.4M |
Net Income | 54.5M | 305.1M | 230.9M | -223.8M | -760.5M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.33B | 2.88B | 2.96B | 3.17B | 1.82B |
Total Liabilities | 1.24B | 1.44B | 1.34B | 1.78B | 1.17B |
Total Equity | 1.09B | 1.45B | 1.62B | 1.38B | 649.3M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 188M | 536M | 321.1M | -34.1M | -206.3M |
Investing | -96.9M | -151M | -225M | -381.3M | 212.3M |
Financing | -35.9M | 69.5M | -141M | 481.2M | -535.7M |
Market Cap | 2.68B |
Price to Earnings Ratio | -0.64 |
Price to Sales Ratio | 0.46 |
Price to Cash Ratio | 4.33 |
Price to Book Ratio | 0.74 |
Dividend Yield | - |
Shares Outstanding | 51.88M |
Average Volume (1 week) | 173.1k |
Average Volume (1 Month) | 62.56k |
52 Week Change | 0.00% |
52 Week High | 51.60 |
52 Week Low | 51.60 |
Spread (Intraday) | 0 (0%) |
Company Name | Emergent Biosolutions Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.emergentbiosolutions.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.